Assay Detail
Functional
CHEMBL4833536
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Anti-hypertrophic cardiomyopathy in po dosed Sprague-Dawley rat assessed as reduction in fractional shortening measured upto 24 hrs by echocardiography
4
Total Activities
2
Compounds Tested
2
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Rattus norvegicus |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 2 | 6.16 | 6.22 |
| IC15 | 2 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4297517 | MAVACAMTEN | 4.0 | 2 | 6.22 |
| CHEMBL4847050 | AFICAMTEN | 3.0 | 2 | 6.10 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4297517 | MAVACAMTEN | IC50 | = | 600.0 | nM | 6.22 |
| CHEMBL4847050 | AFICAMTEN | IC50 | = | 800.0 | nM | 6.10 |
| CHEMBL4847050 | AFICAMTEN | IC15 | = | 7.9 | uM | - |
| CHEMBL4297517 | MAVACAMTEN | IC15 | = | 1.7 | uM | - |